CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
May 28, 2024 08:00 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
Ocugen Set to Join Russell 3000® Index Effective June 28, 2024
May 28, 2024 07:02 ET
|
Ocugen
MALVERN, Pa., May 28, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Biotechnology for the Non-Biotechnologist: 3-Day Training Course (London, United Kingdom - September 25-27, 2024)
May 28, 2024 04:19 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Biotechnology for the Non-Biotechnologist Training Course" conference has been added to ResearchAndMarkets.com's offering. The importance of the...
TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024
May 28, 2024 03:00 ET
|
TILT Biotherapeutics Oy
HELSINKI, Finland, May 28, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces that it will present two...
Key Growth Opportunities in Global Biotech Investment 2024: Acquiring Rare Disease-focused Biopharma Companies and Investing in Precision Medicine Platform Technology-based Biotech Companies
May 27, 2024 04:29 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Global Biotech Investment, 2024" report has been added to ResearchAndMarkets.com's offering. In this analysis, the report...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
May 24, 2024 08:45 ET
|
FN Media Group LLC
PALM BEACH, Fla., May 24, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the...
Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
May 24, 2024 08:37 ET
|
Stereotaxis, Inc.
Stereotaxis has received CE Mark recertification under the EU’s new Medical Device Regulation (MDR) regulatory framework for all available devices.
Life Science Technical Accounting CPE Update (2-Day Virtual Conference: September 17-18, 2024) - Understand the Latest Accounting Changes in Key Areas
May 24, 2024 07:32 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Life Science Technical Accounting CPE Update 2024" conference has been added to ResearchAndMarkets.com's offering. This conference will cover the...
Single Domain Antibody Platforms MarketResearch 2024-2031: Strategic Collaborations Driving Expansion, Focus on Pioneering Cancer Treatments, US Leads Innovations
May 24, 2024 04:28 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Single Domain Antibody Platforms Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
May 23, 2024 17:00 ET
|
Mural Oncology, Inc.
ARTISTRY-3 trial is being conducted to evaluate less frequent dosing of nemvaleukin alfa, Mural’s late-stage lead candidate Nemvaleukin demonstrated pharmacodynamic proof of mechanism in ARTISTRY-3...